Logo image of SLI

STANDARD LITHIUM LTD (SLI) Stock Fundamental Analysis

NYSEARCA:SLI - NYSE Arca - CA8536061010 - Common Stock - Currency: USD

1.4  +0.08 (+6.06%)

After market: 2.785 +1.39 (+98.93%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SLI. SLI was compared to 152 industry peers in the Metals & Mining industry. SLI has a great financial health rating, but its profitability evaluates not so good. SLI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SLI has reported negative net income.
SLI had a negative operating cash flow in the past year.
In the past 5 years SLI reported 4 times negative net income.
SLI had a negative operating cash flow in each of the past 5 years.
SLI Yearly Net Income VS EBIT VS OCF VS FCFSLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 33.70%, SLI belongs to the top of the industry, outperforming 98.03% of the companies in the same industry.
The Return On Equity of SLI (38.28%) is better than 97.37% of its industry peers.
Industry RankSector Rank
ROA 33.7%
ROE 38.28%
ROIC N/A
ROA(3y)-2.71%
ROA(5y)-11.79%
ROE(3y)-1.78%
ROE(5y)-12.36%
ROIC(3y)N/A
ROIC(5y)N/A
SLI Yearly ROA, ROE, ROICSLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

SLI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLI Yearly Profit, Operating, Gross MarginsSLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, SLI has more shares outstanding
SLI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SLI has been reduced compared to a year ago.
SLI Yearly Shares OutstandingSLI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SLI Yearly Total Debt VS Total AssetsSLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 4.50 indicates that SLI is not in any danger for bankruptcy at the moment.
SLI's Altman-Z score of 4.50 is fine compared to the rest of the industry. SLI outperforms 71.71% of its industry peers.
The Debt to FCF ratio of SLI is 0.03, which is an excellent value as it means it would take SLI, only 0.03 years of fcf income to pay off all of its debts.
SLI has a better Debt to FCF ratio (0.03) than 93.42% of its industry peers.
SLI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
SLI's Debt to Equity ratio of 0.00 is amongst the best of the industry. SLI outperforms 83.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 4.5
ROIC/WACCN/A
WACCN/A
SLI Yearly LT Debt VS Equity VS FCFSLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 4.37 indicates that SLI has no problem at all paying its short term obligations.
SLI has a better Current ratio (4.37) than 79.61% of its industry peers.
SLI has a Quick Ratio of 4.37. This indicates that SLI is financially healthy and has no problem in meeting its short term obligations.
SLI has a better Quick ratio (4.37) than 82.24% of its industry peers.
Industry RankSector Rank
Current Ratio 4.37
Quick Ratio 4.37
SLI Yearly Current Assets VS Current LiabilitesSLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SLI have decreased strongly by -32.19% in the last year.
EPS 1Y (TTM)-32.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

SLI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.82% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75.37%
EPS Next 2Y28.35%
EPS Next 3Y16.01%
EPS Next 5Y15.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLI Yearly Revenue VS EstimatesSLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 20M 40M 60M
SLI Yearly EPS VS EstimatesSLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.1 -0.2 -0.3 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLI. In the last year negative earnings were reported.
Also next year SLI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLI Price Earnings VS Forward Price EarningsSLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SLI is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.11
EV/EBITDA N/A
SLI Per share dataSLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as SLI's earnings are expected to grow with 16.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.35%
EPS Next 3Y16.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STANDARD LITHIUM LTD

NYSEARCA:SLI (4/21/2025, 7:13:09 PM)

After market: 2.785 +1.39 (+98.93%)

1.4

+0.08 (+6.06%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-24 2025-03-24/bmo
Earnings (Next)N/A N/A
Inst Owners10.77%
Inst Owner Change0%
Ins Owners7.21%
Ins Owner Change0%
Market Cap271.52M
Analysts83.33
Price Target2.97 (112.14%)
Short Float %3.76%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-180.3%
Min EPS beat(2)-394.26%
Max EPS beat(2)33.66%
EPS beat(4)2
Avg EPS beat(4)-135.37%
Min EPS beat(4)-394.26%
Max EPS beat(4)33.66%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.76%
PT rev (3m)-14.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)23.39%
EPS NY rev (3m)50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 13.11
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.11
FCFY7.63%
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS1.26
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 33.7%
ROE 38.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.71%
ROA(5y)-11.79%
ROE(3y)-1.78%
ROE(5y)-12.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA N/A
Cap/Depr 23712.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 22.06%
Current Ratio 4.37
Quick Ratio 4.37
Altman-Z 4.5
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3831.17%
Cap/Depr(5y)2403.53%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y75.37%
EPS Next 2Y28.35%
EPS Next 3Y16.01%
EPS Next 5Y15.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.81%
EBIT Next 3Y16.22%
EBIT Next 5Y30.84%
FCF growth 1Y141.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.12%
OCF growth 3YN/A
OCF growth 5YN/A